Prevalence and associated risk factors of peripheral artery disease in virologically suppressed HIV-infected individuals on antiretroviral therapy in Kwara state, Nigeria: a cross sectional study

Table 5 Statistical analysis of anthropometric parameters, clinical characteristics, lipid profile, fasting plasma glucose based on ankle brachial index (ABI) measurement in the study participants

Parameter	Normal ABI (1–1.3) (n = 42)	Borderline ABI (0.9–0.99) (n = 86)	PAD (> 0.9) (n = 22)	P-value	Normal ABI VSborderline ABI P-value	Borderline ABI VS PAD P-value	Normal ABI VS PAD P-value
Age (yrs)	44.67 ± 7.85	43.43 ± 9.50	43.14 ± 7.32	0.713	0.735	0.989	0.786
BMI (Kg/m²)	25.43 ± 6.05	25.08 ± 5.31	26.77 ± 4.86	0.435	0.941	0.401	0.618
WC (cm)	89.55 ± 12.10	89.28 ± 11.38	94.55 ± 10.39	0.149	0.991	0.135	0.991
WHR	0.87 ± 0.05	0.87 ± 0.05	0.89 ± 0.04	0.468	1.000	0.455	0.532
Nadir CD4	281 ± 230	258 ± 242	250 ± 176	0.833	0.853	0.990	0.853
Current CD4	495 ± 248	507 ± 277	518 ± 267	0.946	0.970	0.985	0.945
Duration on ART (yrs)	6.88 ± 3.14	7.55 ± 3.45	8.32 ± 3.75	0.479	0.555	0.611	0.248
FPG (mmHg)	4.57 ± 1.20	4.49 ± 0.56	4.50 ± 0.62	0.268	0.848	0.998	0.938
TC (mmol/L)	4.58 ± 1.02	4.50 ± 0.99	5.15 ± 0.62	0.019*	0.893	0.014*	0.066
TG (mmol/L)	2.21 ± 0.16	2.19 ± 0.15	2.23 ± 0.08	0.397	0.766	0.390	0.768
HDL-C (mmol/L)	1.20 ± 0.06	1.19 ± 0.07	1.19 ± 0.06	0.942	0.948	0.942	1.000
LDL-C (mmol/L)	2.38 ± 1.00	2.31 ± 0.95	2.94 ± 0.64	0.017*	0.907	0.013*	0.038*

Data are presented as mean ± standard deviation. * = significant at P < 0.05. ABI Ankle brachial index, SBP Systolic blood pressure, DBP Diastolic blood pressure, BMI Body mass index, WC Waist circumference, WHR Waist to hip ratio, CVD Cardiovascular disease, TC Total cholesterol, TG Triglyceride, HDL-C high density lipoprotein cholesterol, LDL-C Low density lipoprotein cholesterol, FPG Fasting plasma glucose

ISSN: 1471-2458